A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Aimee Pugh Bernard is affiliated with Immunize Colorado as a volunteer and unpaid board member. Every day, your immune system performs a delicate balancing act, defending you from thousands of ...

The 2025 Nobel prize in physiology or medicine has been awarded to three researchers – Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi – who discovered a key kind of immune cell that helps stop the ...

The Nobel-prize season always kicks off with the award for physiology or medicine, which highlights work in fields such as genetics, cell biology and evolution. This year’s award went to three ...

The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies that neutralize the intended SARS-CoV-2 variant target among recipients, according to a press release from ...

Among patients with pancreatic cancer, the vaccine ELI-002 7P elicited strong mKRAS-specific T cell responses in approximately 99% of patients. In an announcement, the off-the-shelf vaccine ELI-002 7P ...

New research reveals how common respiratory viruses like flu and COVID may reawaken dormant breast cancer cells, leading to metastasis within weeks. U.S. Rep. Tony Gonzales staffer's death under ...

Pfizer and BioNTech report that their updated mRNA COVID-19 vaccine for the 2025–2026 season produced strong immune responses, boosting neutralizing antibody levels by at least fourfold in older ...

Sept 8 (Reuters) - Pfizer (PFE.N), opens new tab and partner BioNTech (22UAy.DE), opens new tab said on Monday their updated COVID-19 vaccine showed an increased immune response in adults aged 65 and ...

Findings from this trial reinforce the preclinical data supporting the approval of the LP.8.1-adapted COVID-19 vaccine for the 2025-2026 season. Topline results were announced from a phase 3 trial ...